In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Pfizer, Akzo Nobel's Organon develop antipsychotic drug

Executive Summary

Akzo Nobel's human healthcare subsidiary Organon USA and Pfizer entered into an exclusive worldwide development and commercialization agreement for Organon's asenapine for schizophrenia and bipolar disorder.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Co-Promotion
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register